Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Qihua GU"'
Autor:
Pengbo Deng, Chengping Hu, Cen Chen, Liming Cao, Qihua Gu, Jian An, Ling Qin, Min Li, Baimei He, Juan Jiang, Huaping Yang
Publikováno v:
Cancer Medicine, Vol 11, Iss 19, Pp 3563-3571 (2022)
Abstract Background Anlotinib as a third‐line or beyond therapy for extensive‐stage small‐cell lung cancer (ES‐SCLC) was studied. This single‐arm phase II trial was to investigate the value of anlotinib plus platinum‐etoposide as first‐
Externí odkaz:
https://doaj.org/article/6cdb6c47e10a42ffa67c659b20701465
Autor:
Pengbo DENG, Chengping HU, Yuanyuan LI, Liming CAO, Huaping YANG, Min LI, Jian AN, Juan JIANG, Qihua GU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 23, Iss 10, Pp 858-865 (2020)
Background and objective Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. We aim to report 3 cases of rare complication of anlot
Externí odkaz:
https://doaj.org/article/c9cca2956fed4e399b08a7a38df39c9b
Autor:
Jiarong Tan, Chengping Hu, Pengbo Deng, Rongjun Wan, Liming Cao, Min Li, Huaping Yang, Qihua Gu, Jian An, Juan Jiang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionEpidermal growth factor receptor (EGFR) 19del and L858R mutation are known as “common mutations” in non-small cell lung cancer (NSCLC) and predict sensitivities to EGFR tyrosine kinase inhibitors (TKIs), whereas 20ins and T790M mutati
Externí odkaz:
https://doaj.org/article/1cf1b6abe0f744189230f16459e24af8
Autor:
Lingling Xian, Dan Georgess, Tait Huso, Leslie Cope, Amy Belton, Yu-Ting Chang, Wenyong Kuang, Qihua Gu, Xiaoyan Zhang, Stefania Senger, Alessio Fasano, David L. Huso, Andrew J. Ewald, Linda M. S. Resar
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-15 (2017)
The function of high mobility group A1 (Hmga1) chromatin remodelling proteins in intestinal stem cells (ISC) is unknown. Here, the authors show that Hmga1 amplifies Wnt/β-catenin signalling to enhance self-renewal and inducesSox9to expand the Paneth
Externí odkaz:
https://doaj.org/article/5e3c00d6fe3d4dd9b4ee8a6610a4fe99
Clinical Characteristics and Prognostic Analysis of 38 Patients with Pulmonary Sarcomatoid Carcinoma
Autor:
Yuanyuan LI, Lili ZHANG, Juan JIANG, Huaping YANG, Liming CAO, Qihua GU, Min LI, Chengping HU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 18, Iss 9, Pp 537-542 (2015)
Background and objective Pulmonary sarcomatoid carcinoma is a rare histologic subtype of non-small cell lung cancer. The effective treatment for this disease has not well defined due to its extremely low morbidity. This study explores the clinicopath
Externí odkaz:
https://doaj.org/article/cfe964f2cdf442dfbbee8bff3e0b48c8
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 4, Pp 326-330 (2010)
Background and objective Epidemiology of lung cancer will be changed along with time and region. The aim of this study is to acknowledge the tendency of primary lung cancer in hunan province in recent years by comparing and analyzing the distribution
Externí odkaz:
https://doaj.org/article/48f4c17e86c047e0b34648036fb65fcb
Publikováno v:
Chinese Journal of Lung Cancer, Vol 12, Iss 5, Pp 403-407 (2009)
Background and objective It has been proved that the chemotherapy respouse was related to the expression levels of tumor genes in lung cancer. The aim of this study was to explor the relationship of ERCC1, RRM1 expression and the benefits from postop
Externí odkaz:
https://doaj.org/article/4323f7352c7a45588a9d4a47b86b07f1
Publikováno v:
Chinese Journal of Lung Cancer, Vol 11, Iss 4, Pp 519-523 (2008)
Background and objective Chinese green tea is one of the daily consumption beverages in the world and is considered a promising cancer chemopreventive agent. In the present study, we investigate the role of lung cancer prevention by green tea and its
Externí odkaz:
https://doaj.org/article/2093068005014a3d97a69acef0ef329e
Publikováno v:
International Journal of General Medicine
Qihua Gu,1,2 Xinhao Deng,1,2 Zhao Li,1,2 Jing Wang,3 Chengping Hu,1,2 Shuhua Lei,1,2 Xiaoling Cai1,2 1Department of Respiratory Medicine, Xiangya Hospital Affiliated to Central South University, Changsha, Hunan Province, 410008, People’s Republic o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d3fd344034664215acd29a0d277570
http://europepmc.org/articles/PMC8068496
http://europepmc.org/articles/PMC8068496
Publikováno v:
Annals of Palliative Medicine. 10:202-209
Background Recent clinical studies have reported that some cytokines are associated with lung cancer prognosis and mortality. However, the relationship between cytokines and clinical outcomes in severe lung cancer patients was unclear. IL-6 as an imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a46eaba56a6d2ae81ee6bd3230938682
https://doi.org/10.21037/apm-20-2229
https://doi.org/10.21037/apm-20-2229